Pfizer Commercial Oncology is focused on advancing cancer care through a portfolio of therapies and a goal of delivering eight breakthroughs by 2030. Pfizer Oncology’s portfolio spans breast, genitourinary, hematology, gastrointestinal and thoracic cancers. The US Breast Cancer Business includes IBRANCE, TUKYSA in metastatic breast cancer, and a pipeline of breast cancer innovation. TUKYSA is approaching an important period, including the anticipated launch of the HER2CLIMB-05 first-line maintenance indication in HER2-positive metastatic breast cancer, with a PDUFA date of October 17, 2026. TUKYSA is also indicated for HER2-positive metastatic colorectal cancer, with pivotal trial readouts anticipated in both indications over the coming years. The Director, US TUKYSA HCP Marketing Lead is a strategic and operational leadership role and an individual contributor in a highly matrixed environment. The Director serves as the strategic architect of TUKYSA HCP marketing, owning positioning, value proposition, core claims and messaging architecture. The role leads the HCP agency partnership and is the primary Marketing partner to Sales for personal promotion, ensuring marketing strategy translates into effective field execution. The Director reports to the Sr. Director, US TUKYSA Lead and works closely with Sales, Insights & Analytics, Medical, Regulatory, Legal and other cross-functional partners. The role also provides strategic direction, coaching and development to HCP marketing colleagues and agency partners.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director